LIPOSOMAL NANOPARTICLES AND OTHER FORMULATIONS OF FENRETINIDE FOR USE IN THERAPY AND DRUG DELIVERY

(19)

(11)

EP 2 013 016 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	08.10.2014 Bulletin 2014/41

(45)	Mention of the grant of the patent:
	06.08.2014 Bulletin 2014/32

(21)	Application number: 07759747.4

(22)	Date of filing: 29.03.2007

(51)

International Patent Classification (IPC):

A61K 9/127^(2006.01)
A61K 47/24^(2006.01)
A61K 31/167^(2006.01)

A61K 9/107^(2006.01)
A61K 47/28^(2006.01)
A61P 35/00^(2006.01)

(86)	International application number:
	PCT/US2007/065556

(87)	International publication number:
	WO 2007/115134 (11.10.2007 Gazette 2007/41)

(54)

LIPOSOMAL NANOPARTICLES AND OTHER FORMULATIONS OF FENRETINIDE FOR USE IN THERAPY AND DRUG DELIVERY

LIPOSOMALE NANOPARTIKEL UND ANDERE FENRETINID-FORMULIERUNGEN FÜR DIE THERAPIE UND WIRKSTOFFFREISETZUNG

NANOPARTICULES DE LIPOSOME ET AUTRES FORMULATIONS DE FENRÉTINIDE UTILES EN THÉRAPIE ET POUR L'APPORT DE MÉDICAMENT

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30)

Priority:

29.03.2006 US 786838 P

(43)	Date of publication of application:
	14.01.2009 Bulletin 2009/03

(73)	Proprietors:
	WAYNE STATE UNIVERSITY Detroit, MI 48202 (US) Scitech Development LLC Grosse Pointe Farms, MI 48236 (US)

(72)	Inventors:
	JASTI, Bhaskara, R. Stockton, CA 95219 (US) PARCHMENT, Ralph, E. Hagerstown, MD 21742 (US) BOINPALLY, Ramesh, R. Broomfield, CO 80020 (US) ROSE, Steven, E. Flushing, MI 48433 (US) HOLSAPPLE, Earle, T. Grosse Pointe Farms, MI 48236 (US)

(74)	Representative: Nederlandsch Octrooibureau
	P.O. Box 29720 2502 LS The Hague 2502 LS The Hague (NL)

(56)

References cited: :

WO-A1-2005/039532
US-A1- 2002 183 394

WO-A1-2005/120469
US-B1- 6 334 999

NORIKO TAKAHASHI ET AL: "Effects on M5076-Hepatic Metastasis of Retinoic Acid and N-(4-Hydroxyphenyl) Retinamide, Fenretinide Entrapped in SG-Liposomes", BIOLOGICAL & PHARMACEUTICAL BULLETIN, vol. 26, no. 7, 1 July 2003 (2003-07-01), pages 1060-1063, XP55000740, ISSN: 0918-6158, DOI: 10.1248/bpb.26.1060

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).